在OSA中通过碳酸胺酶抑制剂Sulthiameame修改内型特征
Erik Hoff1, Christian Strassberger2, Ding Zou2
1Centre for Sleep and Vigilance Disorders, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden; Region Västra Götaland, Department of Infectious Diseases, Södra Älvsborgs Hospital, Borås, Sweden.
Chest
|September 30, 2023
概括
阻塞性睡眠呼吸暂停 (OSA) 的苏尔蒂亚姆治疗可以减少循环增长和上呼吸道缩性. 这些改善的呼吸系统不稳定性和崩性与减少的OSA严重性相关.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
- 睡眠科学 睡眠科学
背景情况:
- 众所周知,碳酸酶抑制剂,如苏,可以减少阻塞性睡眠呼吸暂停 (OSA) 的严重程度.
- 了解sulthiame如何影响OSA内型特征对于呼吸调节的洞察至关重要.
研究的目的:
- 为了研究西治疗对阻塞性睡眠呼吸暂停患者特定内型特征的影响.
- 为了确定苏尔蒂亚姆是否会改变通风系统的不稳定性和上呼吸道的折叠性.
主要方法:
- 一项随机对照试验分析了中度至重度OSA的患者.
- 参与者接受了安慰剂,200毫克或400毫克的苏尔提亚姆4周.
- 在基线和随访时使用了多梦摄影来评估内型特征,并将其与苏胺度相关联.
主要成果:
- 苏尔蒂亚姆显著降低了循环增益 (LG1),这是对通风系统不稳定的衡量标准.
- 治疗增加了最小 (Vmin) 和eupneic (V被动) 驱动器的通风,表明上呼吸道缩性降低.
- 循环增益的减少与呼吸暂停-呼吸暂停指数 (AHI) 的降低相关,而Vmin和Vpassive的变化也与AHI的降低相关.
结论:
- 苏胺在OSA中的有效性可能源于其降低呼吸系统不稳定性的能力 (LG1).
- 这种药物似乎还可以减少上呼吸道的折叠性,这是Vmin和Vpassive的变化证明的.
- 这些发现增强了我们对OSA病理生理学和呼吸控制中的碳酸酶抑制的理解.
相关概念视频
Open Angle Glaucoma: Treatment
474
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
474
Angle Closure Glaucoma: Treatment
555
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
555
Pleiotropy
40.6K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.6K
Oral Hypoglycemic Agents: Sulfonylureas
226
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
226


